Halocynthiaxanthin and Peridinin Sensitize Colon Cancer Cell Lines to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand

@article{Yoshida2007HalocynthiaxanthinAP,
  title={Halocynthiaxanthin and Peridinin Sensitize Colon Cancer Cell Lines to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand},
  author={Tatsushi Yoshida and Takashi Maoka and Swadesh K. Das and Kazuki Kanazawa and Mano Horinaka and Miki Wakada and Yoshiko Satomi and Hoyoku Nishino and Toshiyuki Sakai},
  journal={Molecular Cancer Research},
  year={2007},
  volume={5},
  pages={615 - 625}
}
Carotenoids are compounds contained in foods and possess anticarcinogenic activity. Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) is a promising candidate for cancer therapeutics due to its ability to induce apoptosis selectively in cancer cells. However, some tumors remain tolerant to TRAIL-induced apoptosis. Therefore, it is important to develop agents that overcome this resistance. We show, for the first time, that certain carotenoids sensitize cancer cells to TRAIL-induced… 

Figures and Tables from this paper

Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole

Findings of the present study described novel mechanisms of dipyridamole action and highlighted its promising use as a potential enhancer of TRAIL efficacy.

Ibuprofen enhances TRAIL-induced apoptosis through DR5 upregulation.

It is demonstrated that ibuprofen and TRAIL synergistically induced apoptosis in human colon cancer HCT116 cells but not in normal PBMCs, raising the possibility that ib uprofen may be promising as a safe chemopreventive agent against colon cancer.

Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer

The TRAIL-sensitizing effects of natural products and synthetic compounds in colorectal cancer (CRC) cells are focused on and the molecular mechanisms by which such agents enhance the response of CRC cells to TRAIL are discussed.

Sensitization of Human Carcinoma of Nasopharynx Cells to Doxorubicin and Induction of Apoptosis by Sargassum baccularia Lipophilic Fraction

Investigation of the apoptosis-modulating activities of Sargassum baccularia lipophilic fraction in human carcinoma of nasopharynx cells found that SBL fraction acts as potent sensitizer for doxorubicin-induced apoptosis, and it can be potentially developed into a promising adjuvant therapy for nasophile carcinoma.

Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)

This review aims at discussing the main mechanisms by which TRAIL signaling is regulated and presenting how marine bioactive compounds have been found, so far, to overcome TRAIL resistance in tumor cells.

Siphonaxanthin, a Green Algal Carotenoid, as a Novel Functional Compound

The results of these studies suggested that the anti-angiogenic effect of siphonaxanthin is due to the down-regulation of signal transduction by fibroblast growth factor receptor-1 in vascular endothelial cells.

“Combination-oriented molecular-targeting prevention” of cancer: a model involving the combination of TRAIL and a DR5 inducer

The strategy of “combination-oriented molecular-targeting prevention” of cancer will be a practical approach for chemoprevention against human malignant tumors and many of these agents were found to up-regulate the expression of death receptor 5, a TRAIL receptor.

References

SHOWING 1-10 OF 49 REFERENCES

The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells.

Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.

Data indicate that chemotherapeutic drugs sensitize colon tumor cells to TRAIL-mediated caspase-8 activation and apoptosis, and that cisplatin and doxorubicin sensitize the most resistant colon cancer cell lines to TRAil-induced cell death without modifying the expression nor the localization of TRAIL receptors in these cells.

Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

Death receptor 5 (DR5) is a receptor for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). TRAIL is a promising candidate for cancer therapeutics due to its ability to induce apoptosis

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is regarded as a potential anticancer agent but considerable numbers of cancer cells are resistant to apoptosis induction by TRAIL, and some cancer cells that were originally sensitive to TRAIL-induced apoptosis can become resistant after repeated exposure (acquired resistance).

Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells

It is shown for the first time that the apoptosis by luteolin is mediated through death receptor 5 (DR5) upregulation, and the possibility that treatment with luteolini might be promising as a new therapy against cancer is raised.

Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells.

Findings indicate that treatment with etoposide, Ara-C, or doxorubicin up-regulates DR5 levels in a p53-independent manner and sensitizes human acute leukemia cells to Apo-2L-induced apoptosis.

FADD Is Required for DR4- and DR5-mediated Apoptosis

It is concluded that FADD is required for DR4- and DR5-mediated apoptosis, and stably transfected mouse DR4/5, human DR4, or human DR5 into FADD −/− mouse embryonic fibroblast cells showed that Fadd −-/− MEF cells stablyTransfected with TRAIL receptors are resistant to TRAIL-mediated cell death.

Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

Few breast cell lines are sensitive to TRAIL-induced apoptosis, and no difference in sensitivity is found between normal and malignant cell lines.

Safety and antitumor activity of recombinant soluble Apo2 ligand.

Apo2L may have potent anticancer activity without significant toxicity toward normal tissues, and cooperated synergistically with the chemotherapeutic drugs 5-fluorouracil or CPT-11, causing substantial tumor regression or complete tumor ablation.

Carotenoids in Cancer Chemoprevention

Antioxidative phytoene-containing animal foods may be classified as a novel type of functional food, which has the preventive activity against carcinogenesis, as well as the ability to reduce the accumulation of oxidative damages, which are hazardous for human health.